Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Acta Medica Austriaca|January 1, 1993
[Radiosynovectomy with dysprosium-165 iron hydroxide]C Pirich, A Wanivenhaus, W Graninger, et al.European Journal of Nuclear Medicine|November 5, 1997
Radiation doses deriving from patients undergoing 111In-DTPA-D-phe-1-octreotide scintigraphyA Kurtaran, J Pfreitfellner, P Schaffarich, et al.European Journal of Nuclear Medicine|April 1, 1997
Monitoring of the biodistribution and biokinetics of dysprosium-165 ferric hydroxide with a shadow-shield whole-body counterC Pirich, U Prüfert, E Havlik, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Vasoactive intestinal peptide receptor scintigraphyI Virgolini, A Kurtaran, M Raderer, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinomaM Leimer, A Kurtaran, P Smith-Jones, et al.American Journal of Physiology. Endocrinology and Metabolism|December 18, 2014
Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clampTiffany D Farmer, Erin C Jenkins, Tracy P O'Brien, et al.The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 23, 2004
Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinomaS Li, M Peck-Radosavljevic, O Kienast, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2000
Radiation synovectomy using 165Dy ferric-hydroxide and oxidative DNA damage in patients with different types of arthritisC Pirich, A Pilger, E Schwameis, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 26, 1998
Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patientsI Virgolini, I Szilvasi, A Kurtaran, et al.The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|August 10, 2000
New radiopharmaceuticals for receptor scintigraphy and radionuclide therapyI Virgolini, T Traub, M Leimer, et al.Pageof 3